Division of Gastroenterology, University of California San Diego, La Jolla, California; Division of Gastroenterology, Tufts University Medical Center, Boston, Massachusetts.
Division of Gastroenterology, University of California San Diego, La Jolla, California.
Clin Gastroenterol Hepatol. 2022 Apr;20(4):e750-e760. doi: 10.1016/j.cgh.2021.02.007. Epub 2021 Feb 6.
Despite increasing interest in histologic remission as a treatment target in ulcerative colitis (UC), the accuracy of histologic findings in left colon in detecting pancolonic histologic remission is unknown.
In a retrospective cohort study of patients with endoscopically active pancolitis undergoing treat-to-target interventions, we evaluated the diagnostic accuracy of left-sided (distal to splenic flexure) histologic and endoscopic findings on colonoscopy for detecting histologic and endoscopic healing elsewhere in the colon.
Of 86 patients with moderate to severely active pancolitis who underwent 2 consecutive colonoscopies during treat-to-target interventions, 38% and 51% achieved histologic and endoscopic remission, respectively. Substantial agreement (kappa, 0.67; 95% confidence interval (CI), 0.51-0.83) was observed in histologic findings between left and right colon on follow-up colonoscopy. Histologic, and endoscopic, findings in left colon showed excellent accuracy in detecting pancolonic histologic remission (area under the curve (AUC), 0.96 [95% CI, 0.93-1.0]; misclassification rate, 5.9%), histologic normalization (AUC, 1.0, 0%), endoscopic improvement (AUC, 0.95 [0.96-1.0], 3.5%) and endoscopic remission (AUC, 0.98 [0.96-1.00], 5.8%), respectively.
In patients with active pancolitis undergoing treat-to-target interventions, histologic and endoscopic findings in the left colon on colonoscopy have excellent accuracy for detecting pancolonic histologic remission, histologic normalization, endoscopic improvement, and endoscopic remission. Flexible sigmoidoscopy may suffice for monitoring histologic and endoscopic activity in patients with pancolitis.
尽管人们对溃疡性结肠炎(UC)的组织学缓解作为治疗目标越来越感兴趣,但左半结肠的组织学发现检测全结肠组织学缓解的准确性尚不清楚。
在一项回顾性队列研究中,我们对接受靶向治疗干预的内镜活动期全结肠炎患者进行了研究,评估了左半结肠(脾曲远端)组织学和结肠镜检查的发现对检测全结肠其他部位组织学和内镜愈合的诊断准确性。
在 86 例接受靶向治疗干预的中重度活动性全结肠炎患者中,分别有 38%和 51%的患者达到了组织学和内镜缓解。在后续的结肠镜检查中,左半结肠和右半结肠的组织学发现存在显著的一致性(kappa 值,0.67;95%置信区间(CI),0.51-0.83)。左半结肠的组织学和内镜检查结果在检测全结肠组织学缓解方面具有极好的准确性(曲线下面积(AUC),0.96[95%CI,0.93-1.0];错误分类率,5.9%)、组织学正常化(AUC,1.0,0%)、内镜改善(AUC,0.95[0.96-1.0],3.5%)和内镜缓解(AUC,0.98[0.96-1.00],5.8%)。
在接受靶向治疗干预的活动性全结肠炎患者中,结肠镜检查左半结肠的组织学和内镜学发现对检测全结肠组织学缓解、组织学正常化、内镜改善和内镜缓解具有极好的准确性。对于全结肠炎患者,灵活的乙状结肠镜检查可能足以监测组织学和内镜活动。